Home Blood Pressure Phenotypes and Cardiovascular Remodeling in Hemodialysis

Meng-Kan Chen1,2, Li-Pei Dai3, Ru-Yin Hsu2,4

  • 1Department of Family Medicine, National Taiwan University Hospital, Hsinchu Branch, Hsinchu, Taiwan.

Insights

Home blood pressure monitoring in hemodialysis patients reveals significant misclassification by in-unit readings. Masked hypertension and sustained hypertension are linked to cardiac and vascular changes, while untreated white-coat hypertension also shows risks.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Dialysis-unit blood pressure (BP) inadequately represents true BP burden in hemodialysis (HD) patients.
  • Clinical significance of BP phenotypes like white-coat and masked hypertension in HD is uncertain.
  • Cardiac and vascular remodeling are key concerns in maintenance HD.

Purpose of the Study:

  • To examine associations between BP phenotypes, defined by dialysis-unit and home BP, and cardiac and vascular remodeling in maintenance HD patients.
  • To assess the impact of BP misclassification using standard dialysis-unit BP measurements.
  • To determine the clinical relevance of different BP phenotypes in HD.

Main Methods:

  • 217 adult patients on thrice-weekly HD were classified into BP phenotypes (sustained normotension, white-coat hypertension, masked hypertension, sustained hypertension) using predialysis and home BP.
  • Primary outcomes included left ventricular hypertrophy (LVH) and arterial stiffness (brachial-ankle pulse wave velocity, PWV, baPWV).
  • Multivariable logistic regression and sensitivity analyses were employed, adjusting for relevant covariates.

Main Results:

  • Nearly one-third of patients were misclassified by dialysis-unit BP alone.
  • Sustained hypertension (SHT) was independently associated with LVH and arterial stiffness compared to sustained normotension (SNT).
  • Masked hypertension (MHT) showed the strongest association with arterial stiffness; white-coat hypertension (WCH) was linked to higher arterial stiffness, especially in untreated patients.

Conclusions:

  • Home BP-based phenotyping reveals significant misclassification by dialysis-unit BP in HD patients.
  • SHT and MHT confer the greatest structural burden (cardiac and vascular remodeling).
  • WCH, particularly untreated, is not benign, underscoring the importance of home BP monitoring in dialysis care.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
817
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.8K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.7K